Published in Infect Immun on December 01, 2004
Statistical structure of host-phage interactions. Proc Natl Acad Sci U S A (2011) 1.97
Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother (2010) 1.70
Short-tailed stx phages exploit the conserved YaeT protein to disseminate Shiga toxin genes among enterobacteria. J Bacteriol (2007) 1.21
The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol (2008) 1.13
Design of a seven-genome Escherichia coli microarray for comparative genomic profiling. J Bacteriol (2006) 1.07
Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions. Appl Environ Microbiol (2008) 1.07
Comparative genomics of Shiga toxin encoding bacteriophages. BMC Genomics (2012) 1.07
Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun (2006) 1.06
An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2007) 1.04
The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain. PLoS One (2012) 0.97
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob Agents Chemother (2007) 0.95
Why bacteriophage encode exotoxins and other virulence factors. Evol Bioinform Online (2007) 0.94
Genomic diversity of pathogenic Escherichia coli of the EHEC 2 clonal complex. BMC Genomics (2009) 0.94
Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity. Appl Environ Microbiol (2010) 0.91
Development of monoclonal antibodies and immunoassays for sensitive and specific detection of Shiga toxin Stx2f. PLoS One (2013) 0.88
ppGpp-dependent negative control of DNA replication of Shiga toxin-converting bacteriophages in Escherichia coli. J Bacteriol (2013) 0.86
Inhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvation. Foodborne Pathog Dis (2011) 0.84
Building the microbiome in health and disease: niche construction and social conflict in bacteria. Philos Trans R Soc Lond B Biol Sci (2015) 0.82
Phenethyl isothiocyanate inhibits shiga toxin production in enterohemorrhagic Escherichia coli by stringent response induction. Antimicrob Agents Chemother (2014) 0.79
Isothiocyanates as effective agents against enterohemorrhagic Escherichia coli: insight to the mode of action. Sci Rep (2016) 0.77
Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7. Appl Environ Microbiol (2016) 0.76
UV-Sensitivity of Shiga Toxin-Converting Bacteriophage Virions Φ24B, 933W, P22, P27 and P32. Toxins (Basel) (2015) 0.75
Commensal E. coli Stx2 lysogens produce high levels of phages after spontaneous prophage induction. Front Cell Infect Microbiol (2015) 0.75
Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides. Antimicrob Agents Chemother (2015) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology (1970) 21.42
Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol (2000) 18.21
Standard reference strains of Escherichia coli from natural populations. J Bacteriol (1984) 11.16
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66
Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis (1989) 6.49
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol (1997) 5.62
lambda Repressor and cro--components of an efficient molecular switch. Nature (1981) 4.52
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis (2000) 4.24
Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J Bacteriol (1999) 4.08
Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol (1998) 3.45
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology (2001) 2.65
Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol (2001) 2.59
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis (2000) 2.51
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun (1993) 2.47
In vivo transduction with shiga toxin 1-encoding phage. Infect Immun (1998) 2.16
Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun (1996) 2.13
Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun (2000) 2.01
Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. J Clin Microbiol (1996) 1.91
Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol (2002) 1.83
Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli. Infect Immun (2000) 1.59
Mosaic structure of Shiga-toxin-2-encoding phages isolated from Escherichia coli O157:H7 indicates frequent gene exchange between lambdoid phage genomes. Microbiology (2001) 1.58
Isogenic lysogens of diverse shiga toxin 2-encoding bacteriophages produce markedly different amounts of shiga toxin. Infect Immun (1999) 1.53
Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol (2004) 1.48
Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones. Lancet (1999) 1.48
Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect Immun (2003) 1.47
Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun (2001) 1.47
Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun (2003) 1.44
Characterization of a Shiga toxin-encoding temperate bacteriophage of Shigella sonnei. Infect Immun (2001) 1.37
Arrangement and functional identification of genes in the regulatory region of lambdoid phage H-19B, a carrier of a Shiga-like toxin. Gene (1998) 1.35
Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol (2001) 1.27
Immunity profiles of wild-type and recombinant shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens. Infect Immun (2003) 1.27
Sequence analysis of Stx2-converting phage VT2-Sa shows a great divergence in early regulation and replication regions. DNA Res (1999) 1.08
Reaming as an adjuvant to irrigation on bacterial presence and propagation: an open, cadaveric intramedullary fracture model. J Orthop Trauma (2011) 2.01
A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci U S A (2008) 1.70
Shiga toxin subtypes display dramatic differences in potency. Infect Immun (2011) 1.63
Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun (2003) 1.44
DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infect Immun (2002) 1.14
Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2005) 1.13
Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun (2006) 1.06
Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor. Clin Vaccine Immunol (2007) 1.04
Neutralizing antibodies and persistence of immunity following anthrax vaccination. Clin Vaccine Immunol (2006) 1.04
Characterization of serological responses to pertussis. Clin Vaccine Immunol (2006) 1.04
Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol (2004) 1.03
The PtlE protein of Bordetella pertussis has peptidoglycanase activity required for Ptl-mediated pertussis toxin secretion. J Bacteriol (2002) 1.02
Shiga toxin binding to glycolipids and glycans. PLoS One (2012) 0.98
Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance. Biochemistry (2010) 0.98
Phagocytosis of Bordetella pertussis incubated with convalescent serum. J Infect Dis (2003) 0.97
Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2. PLoS One (2010) 0.95
Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2. Biochemistry (2010) 0.95
Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis. J Bacteriol (2004) 0.94
Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates. Angew Chem Int Ed Engl (2008) 0.94
Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol (2010) 0.93
Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2. J Bacteriol (2004) 0.92
Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infect Immun (2007) 0.90
Acellular pertussis vaccines and complement killing of Bordetella pertussis. Infect Immun (2004) 0.90
Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun (2004) 0.89
Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells. Infect Immun (2004) 0.87
Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2. Bioconjug Chem (2010) 0.87
Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J Immunol (2009) 0.86
Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol Lett (2003) 0.85
Glycan-based high-affinity ligands for toxins and pathogen receptors. Med Res Rev (2010) 0.83
Colorimetric viral detection based on sialic acid stabilized gold nanoparticles. Biosens Bioelectron (2012) 0.82
Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8α/CD3ζ chimeric receptor. Biochemistry (2012) 0.81
Failure of manganese to protect from Shiga toxin. PLoS One (2013) 0.81
Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants. Infect Immun (2013) 0.81
Detection of carbohydrate binding proteins using magnetic relaxation switches. Anal Chem (2010) 0.80
Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun (2006) 0.80
Growth phase influences complement resistance of Bordetella pertussis. Infect Immun (2002) 0.80
Toxicity of anthrax toxin is influenced by receptor expression. Clin Vaccine Immunol (2008) 0.78
Biotinylated bi- and tetra-antennary glycoconjugates for Escherichia coli detection. Chembiochem (2008) 0.77
Capture of uropathogenic E. coli by using synthetic glycan ligands specific for the pap-pilus. Chembiochem (2013) 0.76
Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis. Infect Immun (2003) 0.76
Pertussis toxin B-pentamer mediates intercellular transfer of membrane proteins and lipids. PLoS One (2013) 0.75